Clinical Trial Update: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating tirzepatide for reducing morbidity and mortality in adults with obesity is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight | Phase 3 | Status: ACTIVE_NOT_RECRUITING